BioSpace News Archive

Phathom Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Prior Approval Supplement (PAS) for the reformulation of vonoprazan tablets for both VOQUEZNA TRIPLE PAK.

NEXGEL, Inc. announced that its subsidiary, CG Converting and Packaging, has executed a supply agreement with AbbVie Inc., a global biopharmaceutical company to be a supplier of gel pads to be used with AbbVie’s Rapid Acoustic Pulse device being investigated for improvement in the appearance of cellulite.

23andMe Holding Co. announced a new, non-exclusive data license with GSK plc which extends their collaboration and enables GSK to conduct drug target discovery and other research using the 23andMe database, the world’s largest recontactable resource of genetic and phenotypic information from consented participants.

Centessa Pharmaceuticals plc today announced that members of its management team will participate in the following investor conferences.

Akeso (9926.HK) announced that the results of a phase Ib clinical trial for PD-1/VEGF bispecific antibody ( ivonecimab AK112/SMT112 ) as first- or second-line therapy for advanced or metastatic immunotherapy naïve non-small-cell lung cancer (NSCLC) were published in the Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer (IASLC).

Armata Pharmaceuticals, Inc. today announced that topline data from the Company’s Phase 1b /2a SWARM- P.a. clinical trial evaluating AP-PA02, a novel, inhaled multi-phage therapeutic for the treatment of chronic pulmonary Pseudomonas aeruginosa infections in people with cystic fibrosis (CF) will be mentioned during the North American Cystic Fibrosis Conference (NACFC) Plenary II session.

Karyopharm Therapeutics Inc. today announced that it has entered into a clinical trial collaboration and supply agreement with Bristol-Myers Squibb (NYSE: BMY) to evaluate the company’s proprietary investigational cereblon E3 ligase modulator.

Evoke, an Inizio company and leading global life sciences brand, experience, and communications platform, announced today the appointment of Cris Morton as Group President, Marketing.

Cognito Therapeutics today announced the appointment of Christian Howell as Chief Commercial Officer (CCO).

Burning Rock Biotech Limited is pleased to announce that the Company and Boehringer Ingelheim officially have signed the Master Service Agreement in the field of oncology companion diagnostics.